+

WO2000067708A3 - Compositions d'hormones steroides a administration orale et methodes d'utilisation - Google Patents

Compositions d'hormones steroides a administration orale et methodes d'utilisation Download PDF

Info

Publication number
WO2000067708A3
WO2000067708A3 PCT/US2000/012404 US0012404W WO0067708A3 WO 2000067708 A3 WO2000067708 A3 WO 2000067708A3 US 0012404 W US0012404 W US 0012404W WO 0067708 A3 WO0067708 A3 WO 0067708A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
steroidal hormone
hormone compositions
oral
Prior art date
Application number
PCT/US2000/012404
Other languages
English (en)
Other versions
WO2000067708A2 (fr
Inventor
Vassem Ali
Original Assignee
Univ Texas
Vassem Ali
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Vassem Ali filed Critical Univ Texas
Priority to AU48252/00A priority Critical patent/AU4825200A/en
Publication of WO2000067708A2 publication Critical patent/WO2000067708A2/fr
Publication of WO2000067708A3 publication Critical patent/WO2000067708A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Cette invention concerne des compositions dentifrices comprenant une dose efficace d'oestrogène ou de substance renfermant un l'oestrogène. L'invention porte également sur diverses méthodes d'utilisation de ces compositions, notamment à titre prophylactique ou préventif en cas de perte de dents ou d'ostéoporose, ainsi que sur des kits thérapeutiques contenant une ou plusieurs de ces compositions.
PCT/US2000/012404 1999-05-07 2000-05-05 Compositions d'hormones steroides a administration orale et methodes d'utilisation WO2000067708A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU48252/00A AU4825200A (en) 1999-05-07 2000-05-05 Oral steroidal hormone compositions and methods of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13308599P 1999-05-07 1999-05-07
US60/133,085 1999-05-07

Publications (2)

Publication Number Publication Date
WO2000067708A2 WO2000067708A2 (fr) 2000-11-16
WO2000067708A3 true WO2000067708A3 (fr) 2001-02-08

Family

ID=22456942

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/012404 WO2000067708A2 (fr) 1999-05-07 2000-05-05 Compositions d'hormones steroides a administration orale et methodes d'utilisation

Country Status (2)

Country Link
AU (1) AU4825200A (fr)
WO (1) WO2000067708A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366002A1 (en) * 2000-11-17 2005-01-24 Warner-Lambert Company Llc Treatment of sexual dysfunction using bombesin antagonist
SK622004A3 (en) 2001-07-31 2004-08-03 Pfizer Prod Inc Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
CN114728013A (zh) * 2019-09-23 2022-07-08 斯坦福大学托管董事会 延长妊娠以及月经或妊娠的并发症的治疗方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058564A (en) * 1979-09-07 1981-04-15 Horton J E Pharmaceutical compositions comprising anti-osteoporotic agents
EP0345039A2 (fr) * 1988-05-31 1989-12-06 AMER & COMPANY, INC. Procédé et composition pour le traitement ou la prévention de la plaque ou du tartre dentaires ou de la gingivite
EP0455503A1 (fr) * 1990-05-04 1991-11-06 Colgate-Palmolive Company Composition pour le traitement de l'ostéoporose et du déséquilibre hormonal
US5310545A (en) * 1991-04-11 1994-05-10 Drore Eisen Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter
WO1994016673A1 (fr) * 1993-01-19 1994-08-04 The Gillette Company Bain de bouche
EP0671175A2 (fr) * 1989-11-17 1995-09-13 The Procter & Gamble Company Compositions pharmaceutiques à libération prolongée pour le traitement des maladies périodontales
US5939047A (en) * 1996-04-16 1999-08-17 Jernberg; Gary R. Local delivery of chemotherapeutic agents for treatment of periodontal disease
DE19832169A1 (de) * 1998-07-17 2000-01-27 Jenapharm Gmbh Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058564A (en) * 1979-09-07 1981-04-15 Horton J E Pharmaceutical compositions comprising anti-osteoporotic agents
EP0345039A2 (fr) * 1988-05-31 1989-12-06 AMER & COMPANY, INC. Procédé et composition pour le traitement ou la prévention de la plaque ou du tartre dentaires ou de la gingivite
EP0671175A2 (fr) * 1989-11-17 1995-09-13 The Procter & Gamble Company Compositions pharmaceutiques à libération prolongée pour le traitement des maladies périodontales
EP0455503A1 (fr) * 1990-05-04 1991-11-06 Colgate-Palmolive Company Composition pour le traitement de l'ostéoporose et du déséquilibre hormonal
US5310545A (en) * 1991-04-11 1994-05-10 Drore Eisen Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter
WO1994016673A1 (fr) * 1993-01-19 1994-08-04 The Gillette Company Bain de bouche
US5939047A (en) * 1996-04-16 1999-08-17 Jernberg; Gary R. Local delivery of chemotherapeutic agents for treatment of periodontal disease
DE19832169A1 (de) * 1998-07-17 2000-01-27 Jenapharm Gmbh Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9125816B2 (en) 2000-08-30 2015-09-08 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism
US9132089B2 (en) 2000-08-30 2015-09-15 Besins Healthcare Inc. Pharmaceutical composition and method for treating hypogonadism

Also Published As

Publication number Publication date
WO2000067708A2 (fr) 2000-11-16
AU4825200A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
WO2001070208A3 (fr) Therapie par remplacement d'hormones
HUP0104718A3 (en) Micronized eplerenone compositions, process for their preparation and use thereof for the preparation of pharmaceutical compositions
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
EP0841936A4 (fr) Compositions d'agents therapeutiques de conjugaison stabilises, formulation d'administration et de diagnostic les contenant
ITMI961152A0 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
DK0748190T3 (da) Progestogenfrie formuleringer af GnRH og estrogen til behandling af benigne gynækologiske lidelser
WO2000042992A3 (fr) Compositions pour administration par les muqueuses et procedes associes
AU5181200A (en) Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
WO1999063976A3 (fr) Traitement de diabetes
HUP0201872A3 (en) Steroid compounds and pharmaceutical compositions of the same
AU6152200A (en) Azolylbenzamides and analogues and their use for treating osteoporosis
WO2002074292A3 (fr) Therapie de remplacement d'hormones
AU1460801A (en) Cholesterol reducing sterol compositions, preparation and method of use
WO2001043733A3 (fr) Compositions, trousses, appareil et procedes utiles pour inhiber l'inflammation cephalique
HUP0200173A2 (en) Combined use of estrogen and progestogen, norethindrone acetate and ethinyl estradiol for preparing pharmaceutical compositions for preventing and treating skin aging and acne
AU1262501A (en) Compositions for transdermal and transmucosal administration of therapeutic agents
AU4392199A (en) Medicinal compositions for treating evacuatory insufficiency
MXPA02001631A (es) Composiciones farmaceuticas para administracion oral y topica.
AU5252698A (en) Therapeutic compositions and methods and diagnostic assays for type ii diabetes involving hnf-1
ZA200108001B (en) Processes for making pharmaceutical oral ECB formulations and compositions.
AU6042201A (en) Cancer therapy
HK1050472B (zh) 基於醋酸諾美孕酮和雌激素的激素組合物及其用途
EP1090639A3 (fr) Composition pharmaceutique contenant un corticoide progestatif et un modulateur sélectif du récepteur oestrogénique
WO2000037109A3 (fr) Clathrates de dehydroepiandrosterone et compositions pharmaceutiques correspondantes
HUP0203429A3 (en) Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载